ÂÜÀòÂÒÂ×

David Kallend

Chief Scientific Officer And Chief Medical Officer at DalCor Pharmaceuticals

David Kallend has over 30 years of experience in the pharmaceutical industry. David began their career in 1988 as a House Officer at St Helier Hospitals. In 1989, they became a Research Fellow at the Royal Postgraduate Medical School. In 1995, they were an International Clinical Research Physician at Schering. From 1998 to 2005, they were a Medical Advisor and Lead Global Brand Physician at AstraZeneca. From 2005 to 2013, they were a Global Clinical Leader and PD Group Medical Director at Roche Pharmaceuticals. From 2013 to 2020, they were a SVP and Chief Medical Officer at The Medicines Company, as well as a Senior Vice President and Global Medical Leader Cardiovascular Care and Vice President and Global Medical Director. Since 2020, they have been a Chief Medical Officer at LIB Therapeutics and a Chief Scientific Officer at DalCor Pharmaceuticals.

David Kallend attended Chislehurst and Sidcup Grammar School from 1975 to 1982. David then attended Kings College London from 1982 to 1988, studying Medicine.

Links

Previous companies

AstraZeneca logo